I'm Adam Kraya, a PhD biophysicist turned clinical and translational data scientist. I lead global precision medicine initiatives at CHOP's Center for Data-Driven Discovery in Biomedicine (D3b), focusing on integrating statistics, AI/ML, and multi-omics to optimize clinical trial designs and therapeutic development in oncology. My career spans leadership roles at Janssen and academic training at Penn and NIH, where I built end-to-end computational pipelines and mentored cross-disciplinary teams. I’m passionate about translating complex data into actionable insights through scalable, compliant analytics.

Adam Kraya

I'm Adam Kraya, a PhD biophysicist turned clinical and translational data scientist. I lead global precision medicine initiatives at CHOP's Center for Data-Driven Discovery in Biomedicine (D3b), focusing on integrating statistics, AI/ML, and multi-omics to optimize clinical trial designs and therapeutic development in oncology. My career spans leadership roles at Janssen and academic training at Penn and NIH, where I built end-to-end computational pipelines and mentored cross-disciplinary teams. I’m passionate about translating complex data into actionable insights through scalable, compliant analytics.

Available to hire

I’m Adam Kraya, a PhD biophysicist turned clinical and translational data scientist. I lead global precision medicine initiatives at CHOP’s Center for Data-Driven Discovery in Biomedicine (D3b), focusing on integrating statistics, AI/ML, and multi-omics to optimize clinical trial designs and therapeutic development in oncology.

My career spans leadership roles at Janssen and academic training at Penn and NIH, where I built end-to-end computational pipelines and mentored cross-disciplinary teams. I’m passionate about translating complex data into actionable insights through scalable, compliant analytics.

See more

Experience Level

Expert
Expert
Expert
Expert
Expert
Intermediate
Intermediate
Intermediate
Intermediate
Intermediate
See more

Work Experience

Director, Clinical and Translational Data Science, D3b at Children’s Hospital of Philadelphia (CHOP)
January 1, 2021 - Present
Direct global precision medicine strategies, integrating statistics, AI/ML, and multi-omics analytics to optimize clinical trial designs; provide executive-level insights that define therapeutic development pathways for complex oncology portfolios. Oversee scalable, automated analytical workflows on AWS with GxP compliance to support clinical decision-making and potential regulatory filings. Lead and mentor cross-functional teams across DevOps, Engineering, and Clinical Research to align data science initiatives with R&D goals.
Scientific Committee at Children’s Brain Tumor Network (CBTN)
January 1, 2020 - Present
Serve on the scientific committee guiding translational and precision medicine initiatives for pediatric brain tumors, coordinating data-driven strategy across participating institutions.
Supervisory Data Scientist at Center for Data-Driven Discovery in Biomedicine (D3b), CHOP
January 1, 2020 - January 1, 2021
Oversee data science operations within D3b, provide mentorship to multidisciplinary teams, and ensure rigorous analytics standards and reproducibility across projects.
Translational Data Scientist, Oncology Translational Research at Janssen Pharmaceuticals, Inc. (Johnson and Johnson)
January 1, 2019 - January 1, 2020
Led statistical analysis and data science components of an IND submission for a Novel Molecular Entity (NME); established data governance and provenance strategies to scale R&D productivity; served as primary Data Science liaison across Discovery, Translational, and Clinical departments; authored SAPs for therapy derivation.
Research Fellow, Division of Translational Medicine and Human Genetics at University of Pennsylvania
January 1, 2015 - January 1, 2018
Pioneered predictive modeling and biomarker discovery to inform precision oncology research; designed end-to-end pipelines for high-throughput molecular data; led multidisciplinary teams to investigate therapy response and resistance, translating findings into high-impact publications.

Education

PhD at Perelman School of Medicine, University of Pennsylvania
January 11, 2030 - April 1, 2015
MS at University of Florida
January 11, 2030 - April 1, 2025
BS at University of the Sciences
January 11, 2030 - May 1, 2009

Qualifications

TL1 Certificate: Translational Statistics
January 1, 2018 - January 11, 2026

Industry Experience

Healthcare, Life Sciences, Professional Services